P-glycoprotein-mediated Hoechst 33342 transport out of the lipid bilayer

被引:129
作者
Shapiro, AB [1 ]
Corder, AB [1 ]
Ling, V [1 ]
机构
[1] BRITISH COLUMBIA CANC RES CTR,VANCOUVER,BC V5Z 1L3,CANADA
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1997年 / 250卷 / 01期
关键词
P-glycoprotein; multidrug resistance; Hoechst; 33342; fluorescence; lipids;
D O I
10.1111/j.1432-1033.1997.00115.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
High-level expression of P-glycoprotein, a 170-kDa mammalian plasma membrane ATPase, is the cause of an important and widespread form of cancer multidrug resistance. P-glycoprotein reduces cellular accumulation of an enormous variety of lipophilic compounds. The basis for this broad substrate specificity is not well understood. We explored this issue by measuring the kinetics of transport of the lipophilic P-glycoprotein substrate Hoechst 33342 by P-glycoprotein-rich plasma membrane vesicles from CH(R)B30 cells. Hoechst 33342 is fluorescent when bound to the membrane,but not when in the aqueous medium, allowing movement of the dye out of the membrane to be quantitated by fluorescence intensity. The initial specific rate of transport was directly proportional to the amount of Hoechst 33342 in the lipid phase and inversely proportional to the concentration in the aqueous phase. This demonstrates that P-glycoprotein removes Hoechst 33342 from the lipid membrane, where it concentrates due to its hydrophobicity. Because the membrane concentration of hydrophobic P-glycoprotein substrates is high, it may be that P-glycoprotein need not recognize them with high affinity. Transport of hydrophobic substrates out of the lipid bilayer instead of the cytoplasm thus helps to explain the broad substrate specificity of P-glycoprotein.
引用
收藏
页码:115 / 121
页数:7
相关论文
共 35 条
[1]   UNIDIRECTIONAL FLUXES OF RHODAMINE-123 IN MULTIDRUG-RESISTANT CELLS - EVIDENCE AGAINST DIRECT DRUG EXTRUSION FROM THE PLASMA-MEMBRANE [J].
ALTENBERG, GA ;
VANOYE, CG ;
HORTON, JK ;
REUSS, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) :4654-4657
[2]   Steroid transport, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells [J].
Barnes, KM ;
Dickstein, B ;
Cutler, GB ;
Fojo, T ;
Bates, SE .
BIOCHEMISTRY, 1996, 35 (15) :4820-4827
[3]  
CHEN AY, 1993, CANCER RES, V53, P1332
[4]   A METHOD FOR THE DETERMINATION OF INORGANIC-PHOSPHATE IN THE PRESENCE OF LABILE ORGANIC PHOSPHATE AND HIGH-CONCENTRATIONS OF PROTEIN - APPLICATION TO LENS ATPASES [J].
CHIFFLET, S ;
TORRIGLIA, A ;
CHIESA, R ;
TOLOSA, S .
ANALYTICAL BIOCHEMISTRY, 1988, 168 (01) :1-4
[5]  
Childs S, 1994, Important Adv Oncol, P21
[6]  
Colin M, 1996, ANTICANCER RES, V16, P407
[7]  
DOIGE CA, 1992, BIOCHIM BIOPHYS ACTA, V1109, P161, DOI 10.1016/0005-2736(92)90079-2
[8]   THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE [J].
ENDICOTT, JA ;
LING, V .
ANNUAL REVIEW OF BIOCHEMISTRY, 1989, 58 :137-171
[9]   The role of passive transbilayer drug movement in multidrug resistance and its modulation [J].
Eytan, GD ;
Regev, R ;
Oren, G ;
Assaraf, YG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) :12897-12902
[10]  
GOODNO CC, 1982, METHOD ENZYMOL, V85, P116